Related by context. All words. (Click for frequent words.) 65 Darusentan 64 FUSILEV enhances 64 induced mucositis 64 Hsp# Inhibitor 64 Mg Uk 64 Initiates Phase II 63 Initiates Phase III 63 Completes Patient Enrollment 63 Mg Usa 63 TNF Tumor Necrosis Factor 63 Investigational Treatment 63 3 registrational trial 62 Investigational Oral 62 ® adefovir dipivoxil 62 Aflibercept 62 Bosutinib 62 Crofelemer budesonide foam 62 Vitrasert R 62 Achieves Primary Endpoint 62 metastatic malignant 62 pralatrexate injection folate analogue 62 nilotinib Tasigna ® 62 ® lenalidomide 62 CYT# potent vascular disrupting 62 Initiates Clinical Trial 62 orally inhaled migraine 61 5 FU leucovorin 61 cell carcinoma RCC 61 mitoxantrone plus 61 evaluating tivozanib 61 plus prednisone prednisolone 61 Begins Dosing 61 Refractory Hodgkin Lymphoma 61 cladribine Cladribine Tablets 61 non nucleoside inhibitor 61 combines Zetia 61 treat secondary hyperparathyroidism 61 Successfully Completes Phase 61 CHEAP ONLINE PHARMACY LOW 61 IMPDH inhibitor 61 Presents Preclinical Data 61 cromolyn sodium 61 pregabalin Lyrica 61 Initiates Enrollment 61 myelodysplastic myeloproliferative diseases 61 oral beclomethasone dipropionate 61 humanized therapeutic 61 TO AVOID PREGNANCY WHILE 61 cetuximab Erbitux R 61 progressive metastatic prostate 61 Horizant ™ 61 Shows Efficacy 61 toenail onychomycosis 61 ADVANCE ILLUMINATE 61 approved incretin mimetic 61 R adefovir dipivoxil 60 metastatic colorectal carcinoma 60 IMiDs ® 60 pan histone deacetylase 60 Meets Primary Endpoint 60 PEGylated anti 60 Presents Positive 60 Xeloda ® 60 demonstrated antitumor activity 60 bevacizumab Avastin R 60 Nebulized Formoterol 60 humanized interleukin 6 60 virus HCV protease inhibitor 60 IG HCR ;) CO 60 Shows Promise Against 60 Granted Orphan Drug 60 ATRA IV 60 BCG refractory carcinoma 60 Files IND 60 humanised monoclonal antibody 60 CHEAP ONLINE PHARMACY BEST 60 orally administered inhibitor 60 combines bupropion 60 COPEGUS R 60 IN PATIENTS WITH 60 Study Evaluating 60 Combination REOLYSIN R 60 abacavir sulfate lamivudine 60 Receives Orphan Drug Designation 59 Known generically 59 topical gel formulation 59 vinorelbine tartrate 59 R Saizen R 59 Initiates Clinical 59 novel orally inhaled 59 hypertrichosis occurred 59 itraconazole Sporanox 59 methylnaltrexone bromide 59 CYP#A# CYP#D# 59 orally inhaled 59 Phase 2b Clinical Trial 59 Announces Tentative Approval 59 essential thrombocythemia ET 59 Launches Generic Version 59 5 fluorouracil leucovorin 59 Patients Treated With 59 Novel Oral 59 Demonstrates Positive 59 generation purine nucleoside 59 Commences Phase 59 Initiates Phase 2b 59 vapreotide acetate 59 FDA APPROVES 59 tumor vascular disrupting 59 Angiotensin Converting Enzyme 59 Atripla combines 59 Acute Exacerbations 59 PEGylated Fab fragment 59 Conjugate 59 Previously Treated 59 hyaluronidase enzyme 59 PNP inhibitor 59 peptidic compound 59 Transdermal Patch 59 PRICE GREAT DISCOUNT FREE 59 Initiate Phase 59 ASTEROID 59 intranasal formulation 59 Adenoscan R 59 neuronal nicotinic receptor NNR 59 included exfoliative dermatitis 59 CYP#A# isoenzyme 59 evaluating picoplatin 59 Biogen Genentech 59 patients coinfected 59 Aeolus Pharmaceuticals Announces 59 DNA methyltransferase inhibitors 59 Personalized Immunotherapy 59 Namenda Memantine HCl 59 developing Zerenex ferric 59 non constipating irritable 59 sapacitabine CYC# 59 Proc Am Soc 59 HCV RNA polymerase 59 gets USFDA nod 59 #mg/#mg 59 number NCT# ClinicalTrials.gov 59 hypereosinophilic syndrome 58 Submits NDA 58 selective estrogen receptor modulator 58 AKT inhibitor 58 Drug Candidate 58 treat chronic sinusitis 58 gemifloxacin mesylate tablets fluoroquinolone 58 ergot derivatives 58 migraine headaches neuropathic pain 58 Adjuvant Treatment 58 Oral Fingolimod 58 Initiate Phase III 58 non porcine pancreatic 58 Orally administered 58 AAG geldanamycin analog 58 Desvenlafaxine Succinate 58 related CMV Retinitis 58 Edge STudy 58 lamotrigine Lamictal 58 ritonavir boosted 58 selective antagonist 58 Retisert R 58 beta 1a 58 PRN FDA Approves 58 cisplatin gemcitabine 58 selective kinase inhibitor 58 Topoisomerase II 58 Temsirolimus 58 proprietary polysaccharide 58 daily injectable lipoglycopeptide 58 5 HT2A serotonin 58 Long Term Efficacy 58 Peginterferon alfa 2b 58 GVAX ® 58 Presents Preclinical 58 SPRYCEL ® 58 Intravitreal 58 Isavuconazole 58 selective phosphodiesterase 58 LBH# 58 #-# Full Text 58 Hydrochlorothiazide Tablets 58 milnacipran HCl 58 Warfarin Coumadin 58 Epivir R 58 Interferon alfa 2b 58 interstitial cystitis IC 58 FDA Okays 58 RhuDex R 58 Improves Outcomes 58 Ovitrelle R Serostim 58 dasatinib Sprycel ® 58 advanced metastatic renal 58 anti PlGF 58 Pooled Analysis 58 EPIVIR 58 Lubiprostone 58 M# rationally 58 TO TREAT 58 selective A2A adenosine receptor 58 negative allosteric modulator 58 Receives Orphan Drug 58 e antigen HBeAg 58 ethinyl estradiol tablets 58 Pegloticase 58 pathophysiological effects 58 MKC# MT 58 MAGE A3 ASCI 58 thalidomide Thalomid 58 FDA Accepts 57 NASH Huntington 57 Pathway Inhibitor 57 cyclophosphamide doxorubicin vincristine 57 triggers apoptosis programmed 57 Initiate Clinical Trial 57 adalimumab Humira 57 5 lipoxygenase activating 57 CYP#A# substrate 57 Announce Collaboration Agreement 57 Clinical Trial Evaluating 57 Demonstrates Significant 57 systemic RNAi therapeutic 57 Maven Semantic 57 treat atopic dermatitis 57 Plaquenil 57 Submits Supplemental 57 selective modulator 57 Complicated Skin 57 erosive gastritis 57 Vicriviroc 57 Systemic lupus erythematosus SLE 57 Ziprasidone 57 tumors GIST 57 Merck OSI Pharmaceuticals 57 administered concomitantly 57 compound perifosine 57 SUTENT ® 57 platform HDL Mimetic 57 THAT ARE DIFFICULT TO 57 5 Fluorouracil 57 Panzem NCD 57 Mylan Receives Approval 57 Mycophenolate Mofetil 57 Endocrinol 57 Daclizumab 57 Licenses Novel 57 4 PDE4 enzyme 57 renal failure interstitial lung 57 HYPERTENSION 57 naloxol derivative 57 Demonstrates Efficacy 57 leukotriene receptor antagonist 57 novel emulsion formulation 57 Vytorin combines 57 BUPHENYL R sodium phenylbutyrate 57 Pruvel TM 57 PEG IFN 57 Prednisone Against Refractory 57 Silodosin 57 investigational integrase inhibitor 57 vinca alkaloid 57 FACTIVE ® 57 non resectable 57 Talabostat 57 HGS ETR1 mapatumumab 57 vomiting anorexia stomatitis 57 Intervention Effectiveness 57 Shows Statistically Significant 57 inflammatory PDE 57 cyclophosphamide methotrexate 57 sitagliptin metformin 57 NS5B polymerase 57 brand ciclesonide HFA 57 2A receptor agonist 57 cortisol synthesis 57 metformin sulfonylureas 57 Refractory Angina 57 Amgen Neulasta R 57 Mouse Models 57 Initiates Dosing 57 BEST ONLINE PHARMACY LOWEST 57 abacavir lamivudine 57 molecular imaging radiopharmaceutical 57 Prolongs Survival 57 aripiprazole Abilify 57 Prospective Randomized 57 ABLYNX 57 HIV treatments Reyataz 57 Melphalan 57 Novartis Trileptal 57 Maribavir 57 Zorbtive TM 57 Anticancer Agent 57 highly selective inhibitor 57 inhibitor COX 57 cough dyspnea 57 R emtricitabine 57 Teva Provides Update 57 Levaquin levofloxacin 57 Novel Compound 56 markets COLAZAL 56 Initiates Phase 56 First Patient Enrolled 56 ramipril Altace 56 vaginal candidiasis 56 Valproic acid 56 Submits IND 56 Tyrosine Kinase Inhibitor 56 Statin medicines sold 56 YOUR LOCAL ANIMAL SHELTER 56 Kinase Inhibitor 56 Crixivan 56 containing abacavir 56 IAP inhibitor 56 Receives Approvable Letter 56 AN# topical anti 56 Triamcinolone 56 oral dihydropyrimidine dehydrogenase DPD 56 lansoprazole Prevacid 56 capsules USP 56 oropharyngeal candidiasis OPC 56 antibiotics Cipro 56 PRICES GREAT DISCOUNTS 56 Anti Tumor 56 Lanthanum Carbonate 56 indinavir Crixivan 56 5mg #mg 56 sores onychomycosis nail 56 Submits Biologics License Application 56 investigational hepatitis C 56 astemizole 56 pyrimidine nucleoside analog 56 TRX1 56 tartrate Inhalation Solution 56 candidates Azedra TM 56 Vaccine Adjuvant 56 Patients Receiving 56 Humanized Anti 56 Retisert ® 56 dexamethasone intravitreal implant 56 Imatinib mesylate 56 targeted radiotherapeutic 56 inhalation powder 56 Omacetaxine 56 angioneurotic edema 56 MetroGel 56 influenza BCX# purine nucleoside 56 Treatment Naive Patients 56 KSP inhibitor 56 PI3K/Akt pathway inhibitor 56 highly selective endothelin 56 Antiarrhythmic 56 including cyclosporine methotrexate 56 fosbretabulin 56 Budesonide foam crofelemer 56 Systemic Sclerosis 56 DURIN TM 56 Tibotec Therapeutics division 56 Plavix clopidogrel bisulfate 56 HCl PEPCID ® famotidine 56 THROUGH ITS 56 1mg 2mg 56 protein tyrosine phosphatase 1B 56 DOWNGRADE ALERT WATCH FOR 56 Therapeutic Competitors Companies 56 Tezampanel 56 calcitonin gene related 56 ALTROPANE R 56 Cancer Incidence Mortality 56 imatinib Gleevec ® 56 RhuDex TM 56 Posaconazole 56 irreversible inhibitor 56 cytomegalovirus immune globulin 56 Muraglitazar 56 acute peripheral arterial 56 METOZOLV ™ ODT metoclopramide 56 SPL# Gel vaginal microbicide 56 Preclinical Data 56 oral anti arrhythmic 56 Anidulafungin 56 BY WILLA J. 56 Phase Ib Clinical Trial 56 Factor Receptor 56 receptor tyrosine kinase inhibitor 56 Temodar ® 56 Cardiol 56 hPTH #-# 56 fumarate 56 prochlorperazine 56 refractory gastrointestinal stromal 56 folate analogue metabolic 56 FOLFOX6 56 Indibulin ZIO 56 dasatinib Sprycel 56 NS5b 56 Romidepsin 56 hypoxia activated prodrug 56 rabeprazole 56 chimeric monoclonal antibody 56 prednisone prednisolone plus 56 Node Positive 56 Vitrasert ® 56 NYSE PFE Exelon Rivastigmine 56 Hydralazine 56 nizatidine 56 Nephrol 56 Study Demonstrates 56 peripherally acting 56 IMiDs R 56 Provectus Pharmaceuticals specializes 56 Phase III multicenter 56 topically administered 56 ADP receptor antagonist 56 Fluticasone 56 Reveals Positive 56 Gemzar gemcitabine 56 enzymatically activated within 56 cytidine nucleoside analog 56 HCl capsules 56 Alfacell proprietary ribonuclease 56 Preclinical Study 55 Single Dose 55 Allegra fexofenadine 55 AzaSite Otic 55 Nicotine Vaccine 55 Rigel R# 55 signal transduction inhibitor 55 ALVESCO ® 55 Inhaled Corticosteroids 55 highly purified pasteurized 55 erythematosus 55 Novel Therapeutic 55 chills fever headache 55 BioSante Pharmaceuticals Announces 55 ® bortezomib 55 ALSO CALLED 55 unresectable inoperable 55 Zalypsis 55 oral prodrug 55 investigational protease inhibitor 55 fluoropyrimidine 55 oral nucleoside analogue 55 Vidaza azacitidine 55 developing Bicifadine serotonin 55 Nucleoside 55 delivers fluocinolone acetonide FA 55 lipoglycopeptide 55 semi synthetic lipoglycopeptide 55 Pharma Merck Serono 55 Reports Preclinical Data 55 DG# compounds targeting 55 TREATMENT FOR 55 Strep Staph 55 5mg #mg #mg 55 investigational oral inhibitor 55 Miconazole 55 mequinol 55 Tegretol carbamazepine 55 Polymerase Inhibitor 55 injectable investigational 55 ficlatuzumab 55 investigational antiplatelet agent 55 Darinaparsin 55 novel orally bioavailable 55 BY DAVE VAN 55 Improves Survival 55 orally disintegrating formulation 55 HER2 Positive 55 Sustiva efavirenz 55 Emtriva Viread 55 Oropharyngeal Candidiasis 55 topical antifungal 55 Disease Modifying 55 FS Antihemophilic Factor Recombinant 55 purified inactivated vaccine 55 Anthrax Toxin 55 DRUG DISCOVERY 55 novel histone deacetylase 55 Immunomodulatory 55 nanofiltered plasma derived 55 Sphingomab TM 55 administered intramuscularly 55 Purchase CIALIS Need 55 administered intranasally 55 Antitumor Activity 55 Viagra Soft Cialis Soft 55 Recombinant Human 55 selective orally bioavailable 55 addressing idiopathic pulmonary 55 administered subcutaneously 55 Ropinirole 55 diarrhea fatigue asthenia 55 ® tenofovir disoproxil 55 volociximab 55 Late Breaker 55 pharmacologically active isomer 55 Crit Rev 55 CUT GLASS 55 2 methoxyestradiol 55 Vitamin D analogue 55 XOMA 3AB biodefense 55 multikinase inhibitor 55 GW# [003] 55 Albuferon TM 55 Amgen Neulasta ® 55 oral candidiasis 55 Placebo Controlled 55 triciribine phosphate monohydrate 55 INDUSTRY ASSESSMENTS 55 antimitotic 55 targeted anticancer biopharmaceuticals 55 small molecule tyrosine 55 Therapeutic Competitors Report 55 Pruvel ™ 55 alefacept 55 NEBIDO VANTAS SUPPRELIN LA 55 5 HT2A inverse 55 sedative pentobarbital sodium 55 Genentech Rituxan 55 J Clin 55 dihydroergotamine mesylate DHE 55 humanized monoclonal 55 HALTS 55 investigational oral hepatitis C 55 Accessed #/#/# [001] 55 Investigational Drug 55 brivanib 55 TREATMENT OF 55 fluoxetine HCl 55 Gets FDA Clearance 55 ribavirin USP 55 See CLINICAL PHARMACOLOGY 55 small molecule chemotherapeutic 55 nasal spray formulation 55 Rhinocort 55 receiving VELCADE 55 Monoclonal antibody 55 selectively binds 55 ORENCIA ® 55 Diffuse Large B 55 Aflibercept VEGF Trap 54 mertansine 54 R brand levalbuterol 54 COPEGUS therapy 54 lexidronam injection 54 SHP LN 54 TLR7 agonist 54 AUDIO PROVIDED BY 54 RNAi Therapeutic 54 aldehyde dehydrogenase ALDH2 deficiency 54 Naive Patients 54 anti secretory 54 miconazole Lauriad ® 54 Cancidas 54 Agonist MABA program 54 Viread tenofovir disoproxil fumarate 54 histone deacetylase HDAC inhibitor 54 particularly SANCTURA XR 54 Saquinavir 54 Therapeutic Efficacy 54 Sipuleucel T 54 Company CryoPatch ® 54 liposome injection 54 benzoic acid hyoscyamine sulfate 54 Drug Shows Promise 54 Aldara ® 54 accumulate preferentially 54 fibrosis IPF 54 Multiple Sclerosis Rheumatoid Arthritis 54 ara C 54 sublingual tablet formulation 54 PHARM 54 Effectively Treats 54 PTK# 54 Akt inhibitor 54 pretreatment serum 54 potassium chloride sodium ascorbate 54 Suppository Hydrocortisone Acetate Rectal 54 Nat Rev 54 intravesical infusion therapy 54 MOVIPREP R 54 Pharmacokinetics PK 54 Carbamazepine 54 Enrolls First 54 Orally Active 54 CG# [003] 54 guanylate cyclase type 54 Doripenem 54 Parkinson disease levodopa induced 54 AMPA kainate 54 undergoing elective percutaneous 54 Nebulized 54 Peripheral Arterial 54 polyglutamate 54 Alkeran 54 Cream Hydrocortisone Cream USP 54 p# MAP kinase inhibitor 54 FDA Approves Generic 54 R MSCRAMM 54 Is Well Tolerated 54 RNA antagonists 54 DOWNTREND CALL 54 zoledronate 54 potassium binder 54 Adenoviral 54 Develop Novel 54 Losartan Potassium 54 HCV Protease Inhibitor 54 STENT 54 HIGHER ON #.#X ABOVE 54 imipramine Tofranil 54 Entry Inhibitor 54 PHASE III 54 Bazedoxifene 54 Demonstrates Sustained 54 SHARES SLIDING LOWER DOWN 54 synthase TS 54 peginterferon alpha 2a 54 pan HDAC inhibitor 54 Immunomedics Announces 54 Lymphocytic 54 ALN HPN 54 Calcium Acetate 54 Dimebon latrepirdine 54 etanercept Enbrel 54 phase III isavuconazole 54 Emergent marketed 54 Bone Metastases 54 potent antiproliferative 54 WOMEN WITH 54 TUMORS 54 Unanimously Recommends Approval 54 oral immunomodulatory 54 microtubule inhibitor 54 EVIZON ™ 54 rHuPH# recombinant human 54 abacavir Ziagen 54 targeted antifolate 54 Gastrointestinal Stromal Tumors 54 Voreloxin 54 dihydrofolate reductase 54 receiving chemoradiation therapy 54 propranolol Inderal 54 rapamycin kinase 54 Unigene nasal calcitonin 54 selective adhesion molecule 54 adenosine A2A 54 Osteoporosis Drug 54 AND TRY TO 54 BOX OFFICE FOR 54 failure thrombosis embolism 54 ACAPODENE TM 54 Long acting beta2 54 Previously Untreated 54 investigational antibiotic 54 topical antifungal product 54 Research www. elsevier.com 54 products MKC# PP 54 non peptidic protease 54 Demonstrated Significant 54 Treatment Shows Promise 54 inhibit VEGF 54 TM Aganocide 54 selective inverse agonist 54 Forodesine 54 Lenocta TM sodium stibogluconate 54 sterile lidocaine patch 54 Peginterferon 54 MEDICATIONS 54 #mg #mg #mg [003] 54 Acute Heart Failure 54 Beclomethasone 54 Belerofon 54 IN COMBINATION WITH 54 nasal decolonization 54 Treated Patients 53 Videx Videx EC 53 Arch Neurol 53 PDX pralatrexate 53 Hormone Receptor Positive 53 HBeAg + 53 Carbidopa 53 balsalazide disodium Capsules 53 Halozyme rHuPH# 53 oxacillin penicillin 53 Extended Release tablets 53 white petrolatum Ointment 53 dornase alfa 53 Fluconazole 53 Tenormin 53 metformin XR 53 Anti Tumor Activity 53 fluoroquinolone class 53 Postdoctoral Position 53 HyperAcute 53 Clinical Antipsychotic Trials 53 #:#-#,# CrossRef Medline [001] 53 IS TALKING ABOUT 53 Slows Progression 53 octreotide acetate 53 MULTIPLE MYELOMA 53 includes AstraZeneca Accolate 53 FDA Approvals 53 OncoVex 53 isoform selective 53 isosorbide mononitrate 53 investigational immunotherapy 53 mycophenolic acid 53 hip osteonecrosis avascular 53 Multicenter Randomized Double 53 Nitazoxanide 53 Bifunctional Muscarinic Antagonist Beta2 53 SinuNase ™ 53 inverse agonist 53 Meta Analysis 53 COMPLETES ACQUISITION OF 53 tazarotene 53 vi Immtech ability 53 arteritis 53 vaccine RiVax TM 53 Devise corrective measures 53 Phase 1b Clinical Trial 53 SPOKE TO HER MOTHER 53 dihydrochloride 53 subcutaneously administered 53 Anthracycline 53 uremic pruritus 53 Clindamycin 53 infectious diseases autoimmune diseases 53 Factor VIIa 53 ciprofloxacin Cipro 53 Psoriasis Drug 53 Miacalcin 53 Valtropin 53 IN FIGHT AGAINST 53 % pramoxine HCl 53 Integrase Inhibitor 53 Monopril 53 Novartis Reclast 53 Medoxomil 53 WERE YOU SURPRISED 53 NS#/#A protease 53 #:#-#,# CrossRef Medline [002] 53 Associated Diarrhea 53 Significantly Improves 53 Renal Impairment 53 EGFR tyrosine kinase inhibitor 53 CYT# vascular disrupting 53 Receives Tentative Approval 53 Kinoid 53 FULL IMPACT 53 cough nasopharyngeal pain 53 Lopressor 53 Devout Muslims refrain 53 pneumocystis pneumonia PCP 53 Lassa fever Ebola 53 J Pediatr 53 Zithromax azithromycin 53 radezolid 53 anthracycline derivative 53 DVT prophylaxis cholesterol 53 proteasome inhibitor 53 CDK inhibitor 53 VANOS TM 53 Telithromycin 53 urinary bladder wall 53 International SMI SYNN 53 macrolide antibiotic 53 Janus kinase 53 Antiviral Therapy 53 Sustained Release 53 acyclovir Zovirax 53 LOS ANGELES ANGELS Activated 53 Helps Diagnose 53 COLAZAL R 53 J Nutr 53 Progressive Multifocal Leukoencephalopathy 53 Lowers Risk 53 sunitinib Sutent ® 53 Interferon Beta 53 Idenix Novartis 53 Vincristine 53 #:#-# [023] 53 Cotara ® 53 Floxin 53 Haemophilus b Conjugate 53 mouse xenograft models 53 Migranal 53 Schizophrenia Treatment 53 5 HT4 53 Receives Complete Response 53 Adjunctive 53 Shows Promising 53 oral proteasome inhibitor 53 novel topoisomerase 53 anti botulism antibody 53 dexamethasone Decadron 53 CTAP# Injection 53 Novartis Organon 53 Clinical Trial Data 53 secretory phospholipase A2 53 1MG TAB 53 Using Dip Pen 53 Asthma COPD 53 Chronic Heart Failure 53 tetracycline antibiotic 53 mediated inhibition 53 Curr Opin 53 By Neil Osterweil 53 Erosive 53 chest tightness wheezing 53 Interferon beta 1a 53 virologically suppressed 53 Hypertensive adverse reactions 53 Civacir TM Hepatitis C 53 & GAS REFINING 53 Dose Ranging Study 53 attach auristatin 53 Therapy Improves 53 Subgroup Analysis 53 torezolid 53 nephropathic cystinosis 53 Liposomal 53 Slow Progression 53 STOP COMPLAINING AND 53 SR# [004] 53 Cyclosporin 53 lead molecular radiotherapeutic 53 Novel Treatments 53 TNF Blockers 53 Inhalation Powder 53 non resectable metastatic 53 Oncolytic 53 Oral Suspension USP 53 WHERE DOES IT 53 SYN# 53 Kosan proprietary 52 AZASAN R 52 Extracellular Matrix 52 TO EDUCATE 52 PPI omeprazole 52 broad spectrum cephalosporin 52 ß blockers 52 THE SITE BUY 52 R rilonacept Injection 52 generation Hsp# inhibitor 52 Receives Fast Track 52 RhuDex ® 52 EARNINGS HINDSIGHT #.# 52 LOST HIS 52 Arterial Disease 52 arginine vasopressin AVP 52 Gets Bearish Confirmation 52 Genentech sanofi aventis 52 Cryopyrin Associated Periodic Syndromes 52 muscarinic antagonist 52 Hematology Molecular Pathology 52 sodium sulfate sodium chloride 52 acting neuraminidase inhibitor 52 Respiratory Virus 52 Critical Therapeutics Zyflo 52 DO YOU BELIEVE IN 52 Files Investigational 52 Camptosar ® 52 immunotherapeutic vaccine 52 AMYLIN 52 rifabutin 52 Inc. Nasdaq OXGN 52 EXPANSION OF 52 antagonist LAMA 52 Pradefovir 52 ciprofloxacin hydrochloride 52 Budesonide 52 Oral Laquinimod 52 COMUNICADO DE 52 RAS MAPK pathway 52 Suicidality 52 Hydrochloride Tablets 52 Immunol 52 HepDirect prodrug 52 cyclophosphamide vincristine 52 DIAGNOSTICS 52 Vaccine Shows Promise 52 carmustine 52 Aganocide ® 52 using Innocoll proprietary 52 SIX RO ROG 52 Telaprevir VX 52 CLINICAL STUDIES 52 delivers preprogrammed intermittent 52 penicillin VK 52 PARKINSON 'S DISEASE 52 anionic backbone 52 auristatin E MMAE 52 FROM THE COMPANY 52 forodesine purine nucleoside phosphorylase 52 Novel Antibody 52 used DNA alkylating 52 sapropterin dihydrochloride Phase 52 writer Gu Chuan 52 antisense inhibitors 52 Small Molecules 52 Jodi Picoult Pocket FP 52 periocular infections 52 Salagen 52 Sanofi Aventis Schering Plough 52 Cholesterol Lowering Drug 52 Biomarker Study 52 idiopathic thrombocytopenic purpura ITP 52 Ocular Inflammation 52 Drug Prevents 52 Mouse Model 52 NEW YORK YANKEES Placed 52 calcipotriene 52 BAXTER INTERNATIONAL 52 Services #:#-#,# Abstract 52 Zovirax acyclovir 52 demonstrated anti amnesic 52 intravenous acetaminophen 52 Generic Version 52 P#Y# [001] 52 FDA Approves Drug 52 Reduces Risk 52 selective immunoproteasome inhibitor 52 Shellgel TM injectable viscoelastic 52 By DEEPA BHARATH 52 Protease Inhibitors 52 Test Detects 52 ciclopirox 52 Eases Pain 52 Noxafil 52 lung pancreatic 52 Shows Promise 52 nasally administered 52 Pancreas Cancer Vaccine 52 'S ABILITY TO 52 occlusion PAO 52 Enzastaurin 52 Luteinizing Hormone Releasing Hormone 52 Investigational eFlow Nebulizer System 52 Taro Receives 52 secretes digestive enzymes 52 Transgenomic Pharmacogenomics Services 52 GMX# 52 VASCULAR 52 Moving Average Crossover Alert 52 CURE FOR 52 bronchial inflammation medicine 52 Sun.Star Pampanga Sunnex 52 valent pneumococcal 52 cytomegalovirus retinitis 52 Eur J 52 Delafloxacin 52 ibritumomab tiuxetan 52 polycythemia vera essential thrombocythemia 52 Protease Inhibitor 52 Toxoid 52 rosiglitazone maleate 52 personalized dendritic 52 choriogonadotropin alfa injection 52 virus HBV 52 BIOPHARMA 52 serine protease inhibitor 52 Sumatriptan Succinate 52 hygienic cleansing 52 Therapeutic Antibody 52 Nilotinib 52 candidate SMaRT Replacement 52 #mg/mL 52 monoclonal anti 52 Evaluation Program CTEP 52 EXTENDING THE 52 Zegerid OTC 52 #:#-# [024] 52 Linezolid 52 Gene Mutation Linked 52 Fluorouracil 52 dihydroergotamine 52 selective agonist 52 antiarrhythmic agent 52 M2 subunit 52 LUNG CANCER 52 Autoimmune Disease 52 Oncol 52 SET FOR MARCH 52 include Phenoptin TM 52 potently inhibit 52 Platinum Resistant Ovarian 52 nicotinic channel 52 PPAR gamma agonist 52 difficile associated 52 vaccine RiVax ™ 52 SKIN CANCER 52 developing sterile lidocaine 52 THYROID 52 AND ECONOMIC